Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ZAI LAB LIMITED

(ZLAB)
  Report
Real-time Estimate Cboe BZX  -  12:05 2022-11-29 pm EST
34.62 USD   +11.50%
10:55aHopes of Easing COVID Restrictions Boost Asian Equities
MT
11/18JPMorgan Chase Lowers Price Target on Zai Lab to $79 From $96, Maintains Overweight Rating
MT
11/17Asian Equities Diverge From US Markets, Climb in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
All news about ZAI LAB LIMITED
10:55aHopes of Easing COVID Restrictions Boost Asian Equities
MT
11/18JPMorgan Chase Lowers Price Target on Zai Lab to $79 From $96, Maintains Overweight Rat..
MT
11/17Asian Equities Diverge From US Markets, Climb in Thursday Trading
MT
11/15Zai Lab Grants American Depositary Shares
MT
11/11Asian ADRs Surge Higher in Friday Trading as China Eases COVID-19 Restrictions
MT
11/11Citigroup Adjusts Price Target on Zai Lab to $127 From $199, Maintains Buy Rating
MT
11/10Asian ADRs Soar in Thursday Trading Following US Inflation Data
MT
11/10Transcript : Zai Lab Limited, Q3 2022 Earnings Call, Nov 10, 2022
CI
11/09Zai Lab's Q3 Net Loss Widens
MT
11/09Zai Lab Reports Wider Q3 Loss, Higher Revenue
MT
11/09ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of..
AQ
11/09Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended Se..
CI
11/09Earnings Flash (ZLAB) ZAI LAB LIMITED Posts Q3 Revenue $57.5M
MT
11/09Zai Lab Announces Third Quarter 2022áFinancial Results and Corporate Updates
GL
11/08Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer An..
GL
11/08Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
GL
11/08Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
AQ
11/08Zai Lab Limited Announces the Appointment of Peter Huang as Chief Scientific Officer
CI
11/02Asian ADRs Move Slightly Higher in Wednesday Trading
MT
11/01Asian ADRs Surge Higher in Tuesday Trading
MT
10/31Zai Lab Announces Participation in November Investor Conferences
GL
10/31Zai Lab Announces Participation in November Investor Conferences
GL
10/28Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K)
AQ
10/28Asian ADRs Move Lower in Friday Trading
MT
10/27Asian ADRs Move Lower in Thursday Trading
MT
10/25Asian ADRs Move Higher in Tuesday Trading
MT
10/24Asian ADRs Tumble in Monday Trading
MT
10/21Asian ADRs Move Lower in Friday Trading
MT
10/18Asian ADRs Move Lower in Tuesday Trading
MT
10/18Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022
GL
10/14Zai Lab Launches its first Trust Report
GL
10/14Zai Lab Launches its first Trust Report
AQ
10/05Zai Lab Grants Share Options Under Equity Incentive Scheme
MT
09/29Zai Lab's H1 Loss Narrows to $220 Million; Shares Slip 6%
MT
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
MT
09/27Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
MT
09/27Zai Lab : Corporate Presentation
PU
09/27Zai Lab Ltd : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ..
AQ
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
GL
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
CI
09/21Asian ADRs Move Lower in Wednesday Trading
MT
09/20Zai Lab to Present Analysis of the Impact of Timing for ZEJULA« (niraparib) Maintenance..
GL
09/20Zai Lab to Present Analysis of the Impact of Timing for ZEJULA« (niraparib) Maintenance..
AQ
09/20Zai Lab to Present Analysis of the Impact of Timing for ZEJULA« Maintenance Treatment i..
CI
09/12DRI Healthcare Trust Acquires Royalty Interest in Zejula, Currently Approved for Treatm..
MT
09/09Asian ADRs Climb Sharply Higher in Friday Trading
MT
09/08Transcript : Zai Lab Limited Presents at Citi's 17th Annual BioPharma Confere..
CI
08/29US, China Reach Audit Deal to Prevent Delistings
MT
08/26Zai Lab : Updated Statement on SEC Listing Matter
PU
08/23Zai Lab Announces Participation in September Investor Conferences
GL
08/12Zai Lab : Argenx Announces European Commission Approval of VYVGART™ (efgartigimod al..
PU
08/10Asian ADRs Move Sharply Higher in Wednesday Trading
MT
08/10Transcript : Zai Lab Limited, Q2 2022 Earnings Call, Aug 10, 2022
CI
08/10Zai Lab : Corporate Presentation
PU
08/10Zai Lab Narrows Q2 Loss as Revenue Jumps 30%; Shares Slide 6%
MT
08/09Zai Lab Reports Narrower Q2 Loss, Higher Revenue; Shares Up After Hours
MT
08/09Zai Lab : Announces Second Quarter 2022 Financial Results and Corporate Updates - Form 8-K
PU
08/09ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of..
AQ
08/09Earnings Flash (ZLAB) ZAI LAB LIMITED Reports Q2 Revenue $48.2M, vs. Street Est of $47...
MT
08/09Zai Lab Announces Second Quarter 2022 Financial Results and Corporate Updates
GL
08/09Zai Lab Limited Reports Earnings Results for the Second Quarter and Six Months Ended Ju..
CI
08/09Citigroup Adjusts Zai Lab's Price Target to $199 From $193, Reiterates Buy Rating
MT
08/08Asian ADRs Move Slightly Lower in Monday Trading
MT
08/08Karuna Therapeutics, Zai Lab Shares Higher After Trial Data for KarXT
DJ
08/08Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 ..
GL
08/08Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 Emergent-2 ..
CI
08/08Zai Lab Shares Rise After Karuna Therapeutics Reports Positive KarXT Data
DJ
08/03Zai Lab Names Operations Chief
MT
08/03Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K)
AQ
08/03Zai Lab Limited Appoints Joshua Smiley as Chief Operating Officer
CI
07/27SEC Chair Stresses Need to Reach Audit Deal With Chinese Regulators
MT
07/26China’s Securities Watchdog Denies Plan to Help Firms Avoid US Delisting
MT
07/20Deal to Avoid Delisting of 200 Firms in US Bourses Remains Unclear
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ZAI LAB LIMITED